Paeoniflorin ameliorates chronic colitis via the DR3 signaling pathway in group 3 innate lymphoid cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Paeoniflorin ameliorates chronic colitis via the DR3 signaling pathway in group 3 innate lymphoid cells

Published:2024-06 Issue:6 Volume:14 Page:100940
ISSN:2095-1779
Container-title:Journal of Pharmaceutical Analysis
language:en
Short-container-title:Journal of Pharmaceutical Analysis

Author:

Huang Shaowei,Xie Xueqian,Xu Bo,Pan Zengfeng,Liang Junjie,Zhang Meiling,Pan Simin,Wang Xiaojing,Zhao Meng,Wang Qing,Chen Jinyan,Li Yanyang,Zhou Lian,Luo Xia

Funder

National Natural Science Foundation of China

Guangdong Provincial Natural Science Foundation

Publisher

Elsevier BV

Reference34 articles.

1. ECCO guidelines on therapeutics in ulcerative colitis: Medical treatment;Raine;J. Crohns Colitis,2022

2. New therapeutics for ulcerative colitis;Hirten;Annu. Rev. Med.,2021

3. Intestinal barrier healing is superior to endoscopic and histologic remission for predicting major adverse outcomes in inflammatory bowel disease: The prospective ERIca trial;Rath;Gastroenterology,2023

4. Activation of DR3 signaling causes loss of ILC3s and exacerbates intestinal inflammation;Li;Nat. Commun.,2019

5. Survival advantages conferred to colon cancer cells by E-selectin-induced activation of the PI3K-NFκB survival axis downstream of death receptor-3;Porquet;BMC Cancer,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP